Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

Aquagenic Pruritus Among Patients With Myeloproliferative Syndromes (in English) Prurit Aquagénique Dans Les SYndromes MyéloProLifEratifs (in French)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03688490

Acronym

PASYMPLE

Enrollment

Registered

2018-09-28

Start date

2013-07-17

Completion date

2013-11-04

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myeloproliferative Disorder

Keywords

aquagenic pruritus

Brief summary

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms. Prospective work based on the distribution of a dedicated questionnaire.

Detailed description

Patients with myeloproliferative neoplasms identified and followed in our Institution (Brest University Hospital). Patients could be followed for polycythemia vera or essential thrombocythemia or myelofibrosis. Distribution of the questionnaire to each patients with myeloproliferative neoplasms (treated or not) suffering from aquagenic pruritus. Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patients followed with myeloproliferative neoplasms * suffering from aquagenic pruritus

Exclusion criteria

* Unable to fulfil the questionnaire * No written informed consent

Design outcomes

Primary

Measure	Time frame	Description
Intensity of the pruritus	15 days	Analogic Visual Scale, from 0 to 10, Worse if \>6

Secondary

Measure	Time frame	Description
Duration of the pruritus	15 days	Timing expresses in minutes

Outcome results